Cannabis Science Appoints Former GlaxoSmithKline Global Director of HIV Research Dorothy Bray, Ph.D., to Scientific Advisory Board Focusing on CS-TATI-1 and Other Emerging Scientific Investigations
08:51 EDT 14 Jun 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Cannabis Science Inc (CBIS) announced today the appointment of Dorothy
Bray, Ph.D., Former Global Director of HIV Research and Senior Clinical
Program Head of HIV and Opportunistic Infections for GlaxoSmithKline, to
the Companyâ...
Other Sources for this Article
Cannabis Science Inc.
Dr. Robert J. Melamede
President
& CEO
1-888-889-0888
info@cannabisscience.com
www.cannabisscience.com
or
Robert
Kane
VP Investor Relations
1-561-234-6929
rkane@cannabisscience.com
info@cannabisscience.com
www.cannabisscience.com
More From BioPortfolio on "Cannabis Science Appoints Former GlaxoSmithKline Global Director of HIV Research Dorothy Bray, Ph.D., to Scientific Advisory Board Focusing on CS-TATI-1 and Other Emerging Scientific Investigations"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
